All Updates

RALEIGH, N.C. – As North Carolina lawmakers begin the 2026 legislative session, the American Cancer Society Cancer Action Network (ACS CAN) urges them to prioritize HB567 , legislation that will ease the burden of cancer on North Carolinians by increasing access to biomarker testing for those with state-regulated health

NASHVILLE, Tenn. – The Tennessee Senate unanimously passed a bill to expand coverage of biomarker testing on Thursday, April 16, sending it to the desk of Gov. Bill Lee. SB0435 would expand coverage of biomarker testing for patients enrolled in state employee health insurance plans and TennCare.

Advocates, including cancer patients, survivors and caregivers with the American Cancer Society Cancer Action Network (ACS CAN) applaud the Guam Department of Public Health and Social Services for updating the school health requirements to include the Human Papillomavirus (HPV) vaccine for middle-school entry. This milestone reflects years of sustained relationship-building,

WASHINGTON, DC – APRIL 16, 2026 – The American Cancer Society Cancer Action Network (ACS CAN) released a new report today showing the scope of cancer disparities in the United States and recommended local, state and federal policies that can help reduce them. Cancer Disparities: An American Cancer Society Cancer Action Network Chartbook examines disparities in cancer screening, prevention and early detection, disparities in cancer incidence, mortality and survival, as well as disparities in access to health coverage.

WASHINGTON, DC – APRIL 16, 2026 – The American Cancer Society Cancer Action Network (ACS CAN) released a new report today showing the scope of cancer disparities in the United States and recommended local, state and federal policies that can help reduce them. Cancer Disparities: An American Cancer Society Cancer Action Network Chartbook examines disparities in cancer screening, prevention and early detection, disparities in cancer incidence, mortality and survival, as well as disparities in access to health coverage.

Cancer Advocates Applaud the Senate’s Passage of Biomarker Testing Legislation, Ensuring Illinoisans Have Better Access to Personalized Care.

Cancer Advocates Applaud the Senate’s Passage of Biomarker Testing Legislation, Ensuring Illinoisans Have Better Access to Personalized Care.

BOISE, Idaho –– More Idaho cancer patients will have easier and more affordable access to oral chemotherapy drugs thanks to House Bill 648, passed by the Idaho Legislature and signed into law this session by Gov. Brad Little. The bill requires state-regulated health insurance plans to equalize out-of-pocket costs between

DES MOINES, Iowa – “Iowa has the 2nd highest cancer rates in the country, and our cancer incidence continues to rise year over year. The state legislature’s vote to restrict access to the Human Papillomavirus (HPV) vaccine for minors will make our cancer crisis worse. Childhood vaccinations are a powerful